REPORT ID 3394

EMEA (Europe, Middle East and Africa) Glucose Dependent Insulinotropic Receptor Market Report 2017

Publish Date
13-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the EMEA Glucose Dependent Insulinotropic Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Glucose Dependent Insulinotropic Receptor for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Glucose Dependent Insulinotropic Receptor market competition by top manufacturers/players, with Glucose Dependent Insulinotropic Receptor sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amgen Inc
    Arena Pharmaceuticals Inc
    CymaBay Therapeutics Inc
    Dong-A Socio Holdings Co Ltd
    F. Hoffmann-La Roche Ltd
    GlaxoSmithKline Plc
    Hyundai Pharmaceutical Co Ltd
    Kowa Co Ltd
    Merck & Co Inc
    Novartis AG
    Taisho Pharmaceutical Holdings Co Ltd
    Takeda Pharmaceutical Co Ltd
    Yuhan Corp

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    DA-1241
    GSK-2041706
    HD-0471042
    HD-0471953
    HOB-047
    MBX-2982
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Type 2 Diabetes
    Obesity
    Chronic Obstructive Pulmonary Disease (COPD)
    Dyslipidemia
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Glucose Dependent Insulinotropic Receptor Market Report 2017
1 Glucose Dependent Insulinotropic Receptor Overview
    1.1 Product Overview and Scope of Glucose Dependent Insulinotropic Receptor
    1.2 Classification of Glucose Dependent Insulinotropic Receptor
        1.2.1 EMEA Glucose Dependent Insulinotropic Receptor Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Glucose Dependent Insulinotropic Receptor Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 DA-1241
        1.2.4 GSK-2041706
        1.2.5 HD-0471042
        1.2.6 HD-0471953
        1.2.7 HOB-047
        1.2.8 MBX-2982
        1.2.9 Others
    1.3 EMEA Glucose Dependent Insulinotropic Receptor Market by Application/End Users
        1.3.1 EMEA Glucose Dependent Insulinotropic Receptor Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Type 2 Diabetes
        1.3.3 Obesity
        1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
        1.3.5 Dyslipidemia
        1.3.6 Others
    1.4 EMEA Glucose Dependent Insulinotropic Receptor Market by Region
        1.4.1 EMEA Glucose Dependent Insulinotropic Receptor Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Glucose Dependent Insulinotropic Receptor (2012-2022)
        1.5.1 EMEA Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2022)

2 EMEA Glucose Dependent Insulinotropic Receptor Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Glucose Dependent Insulinotropic Receptor Market Competition by Players/Manufacturers
        2.1.1 EMEA Glucose Dependent Insulinotropic Receptor Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Glucose Dependent Insulinotropic Receptor Sale Price by Players (2012-2017)
    2.2 EMEA Glucose Dependent Insulinotropic Receptor (Volume and Value) by Type/Product Category
        2.2.1 EMEA Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Glucose Dependent Insulinotropic Receptor Sale Price by Type (2012-2017)
    2.3 EMEA Glucose Dependent Insulinotropic Receptor (Volume) by Application
    2.4 EMEA Glucose Dependent Insulinotropic Receptor (Volume and Value) by Region
        2.4.1 EMEA Glucose Dependent Insulinotropic Receptor Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Glucose Dependent Insulinotropic Receptor Sales Price by Region (2012-2017)

3 Europe Glucose Dependent Insulinotropic Receptor (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Glucose Dependent Insulinotropic Receptor Sales and Value (2012-2017)
        3.1.1 Europe Glucose Dependent Insulinotropic Receptor Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2017)
    3.2 Europe Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type
    3.3 Europe Glucose Dependent Insulinotropic Receptor Sales and Market Share by Application
    3.4 Europe Glucose Dependent Insulinotropic Receptor Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Glucose Dependent Insulinotropic Receptor Sales Volume by Countries (2012-2017)
        3.4.2 Europe Glucose Dependent Insulinotropic Receptor Revenue by Countries (2012-2017)
        3.4.3 Germany Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        3.4.4 France Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        3.4.5 UK Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        3.4.6 Russia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        3.4.7 Italy Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)

4 Middle East Glucose Dependent Insulinotropic Receptor (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Glucose Dependent Insulinotropic Receptor Sales and Value (2012-2017)
        4.1.1 Middle East Glucose Dependent Insulinotropic Receptor Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2017)
    4.2 Middle East Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type
    4.3 Middle East Glucose Dependent Insulinotropic Receptor Sales and Market Share by Application
    4.4 Middle East Glucose Dependent Insulinotropic Receptor Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Glucose Dependent Insulinotropic Receptor Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Glucose Dependent Insulinotropic Receptor Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        4.4.4 Israel Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        4.4.5 UAE Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        4.4.6 Iran Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)

5 Africa Glucose Dependent Insulinotropic Receptor (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Glucose Dependent Insulinotropic Receptor Sales and Value (2012-2017)
        5.1.1 Africa Glucose Dependent Insulinotropic Receptor Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2017)
    5.2 Africa Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type
    5.3 Africa Glucose Dependent Insulinotropic Receptor Sales and Market Share by Application
    5.4 Africa Glucose Dependent Insulinotropic Receptor Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Glucose Dependent Insulinotropic Receptor Sales Volume by Countries (2012-2017)
        5.4.2 Africa Glucose Dependent Insulinotropic Receptor Revenue by Countries (2012-2017)
        5.4.3 South Africa Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)

6 EMEA Glucose Dependent Insulinotropic Receptor Manufacturers/Players Profiles and Sales Data
    6.1 Amgen Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Arena Pharmaceuticals Inc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 CymaBay Therapeutics Inc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Dong-A Socio Holdings Co Ltd
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 F. Hoffmann-La Roche Ltd
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 GlaxoSmithKline Plc
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Hyundai Pharmaceutical Co Ltd
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Kowa Co Ltd
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Merck & Co Inc
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Novartis AG
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Novartis AG Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Taisho Pharmaceutical Holdings Co Ltd
    6.12 Takeda Pharmaceutical Co Ltd
    6.13 Yuhan Corp

7 Glucose Dependent Insulinotropic Receptor Manufacturing Cost Analysis
    7.1 Glucose Dependent Insulinotropic Receptor Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Glucose Dependent Insulinotropic Receptor

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Glucose Dependent Insulinotropic Receptor Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Glucose Dependent Insulinotropic Receptor Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Glucose Dependent Insulinotropic Receptor Market Forecast (2017-2022)
    11.1 EMEA Glucose Dependent Insulinotropic Receptor Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Glucose Dependent Insulinotropic Receptor Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Glucose Dependent Insulinotropic Receptor Price and Trend Forecast (2017-2022)
    11.2 EMEA Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Glucose Dependent Insulinotropic Receptor Sales Forecast by Type (2017-2022)
    11.7 EMEA Glucose Dependent Insulinotropic Receptor Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources